Circle is bringing native USDC issuance and its Cross-Chain Transfer Protocol (CCTP) to Injective, a Layer 1 blockchain focused on derivatives and on-chain financial applications. The integration gives Injective developers and traders direct access to USDC for trading, lending, and settlement.
Users will also be able to move the stablecoin between Injective and other supported chains without relying on wrapped tokens or third-party bridges.
Injective Gets Native USDC Issuance With Full Reserve Backing
USDC on Injective will be issued natively by Circle rather than bridged from another chain. The token will carry the same 1:1 dollar backing and redemption rights as USDC on Ethereum, Solana, or any other natively supported network.
For Injective’s ecosystem, which is built around an on-chain central limit order book and supports spot, derivatives, and structured product trading, native USDC provides a regulated base asset for collateral, settlement, and liquidity across applications.
Previously, users relied on bridged stablecoins or conversions between native tokens to interact with Injective-based markets. Circle said testnet USDC is already available for developers through its faucet, with mainnet deployment to follow.
CCTP Eliminates Bridge Risk for Cross-Chain USDC Transfers
CCTP handles cross-chain movement by burning USDC on the source chain and minting it on the destination chain, maintaining Circle’s reserve backing throughout. The mechanism avoids the lock-and-mint model used by traditional bridges, which has been the source of billions of dollars in exploit losses across the industry.
Injective joins a supported network list that already includes Ethereum, Arbitrum, Optimism, Base, Solana, and others. The integration connects Injective’s trading infrastructure to the broader CCTP liquidity network, allowing users to move USDC in and out of the ecosystem without bridging risk or wrapped-asset friction.
For cross-chain traders and liquidity providers, the practical effect is simpler deposits and withdrawals. Capital can move between Injective and other CCTP-supported chains in a single step.
Launch Fits Injective’s Push for Institutional DeFi Adoption
The launch fits Injective’s broader effort to attract institutional DeFi activity. The network has seen growing adoption for derivatives trading and cross-chain applications, and direct access to native USDC could deepen liquidity across the protocol’s trading and lending markets. Circle described the integration as an important step for both companies.






